Sumitomo Pharma America, Inc. · 2 days ago
Director, Program Management
US-Remote
Full-time
Onsite
Director/Executive
$178K/yr - $222K/yr
10+ years exp
Maximize your interview chancesPharmaceuticals
Insider Connection @Sumitomo Pharma America, Inc.
Get 3x more responses when you reach out via email instead of LinkedIn.
Responsibilities
Lead cross-functional program team(s) to develop strategic plans for compounds integrating development, commercial, technical, and financial considerations.
Drive program team decision-making and management of early-stage compounds to better understand the science and establish clinical development plans.
Apply oncology drug development knowledge and experience to ensure that product candidates are managed in the efficient and rigorous manner as reflected in the design and conduct of studies with a high degree of technical, regulatory, and commercial success.
Ability to translate cross-functional program issues into functional implications.
Be responsible for issue identification and development of an action plan for resolution. Escalation to functional leadership and/or R&D Leadership, when needed.
Drive effective and impactful communication related to program strategy to ensure active management of issues/risks/decisions/opportunities related to all internal and external activities.
Ensure collaboration across the Program Team to achieve maximum team effectiveness.
Perform other duties as assigned.
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
Experience in early clinical stage drug development in oncology /immuno-oncology required.
Strong analytical and creative problem-solving mindset.
Ability to identify key priorities, align strategic and tactical plans, and motivate cross-functional teams and drive effective partnerships across functions.
Outstanding relationship building and communication skills, including ability to navigate throughout the organization rapidly and with individuals at all levels.
Strong holistic perspective of drug development process and life cycle management across different functional areas including familiarity with commercial, medical affairs, clinical and pharmacology, preclinical research, finance, regulatory and compliance groups.
Strong program management skills required.
High degree of organizational awareness, ability to connect the dots to understand all the interdependency and big picture.
Minimum 10 – 15 years (w/o Masters) or 8 – 12 years (with Master’s) of relevant experience in biotech or pharmaceutical industry.
A minimum of 7 years R&D program management experience leading cross-functional teams.
Bachelor’s degree required; advanced degree preferred.
Experience in early clinical stage drug development in oncology /immuno-oncology required.
Preferred
Understanding of the development process and regulatory requirements for in vitro diagnostics (IVDs) highly desirable.
Benefits
Merit-based salary increases
Short incentive plan participation
Eligibility for our 401(k) plan
Medical, dental, vision, life and disability insurances
Unlimited paid time off
11 paid holidays
Additional time off for a shut-down period during the last week of December
80 hours of paid sick time upon hire and each year thereafter
Company
Sumitomo Pharma America, Inc.
Sumitomo Pharma America (SMPA) is a science-based, technology-driven biopharmaceutical company focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need in oncology, urology, women’s health, rare disease, cell and gene therapies and psychiatry and neurology.
1001-5000 employees
H1B Sponsorship
Sumitomo Pharma America, Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2023 (5)
Funding
Current Stage
Late StageLeadership Team
Adele Gulfo
Chief Executive Officer, Biopharma Commercial
Myrtle Potter
President and Chief Executive Officer, Sumitomo Pharma America
Company data provided by crunchbase
